The active thyroid hormone, triiodothyronine (T 3 ), binds to thyroid hormone receptors (TR) and plays an essential role in the control of chondrocyte proliferation and differentiation. Hypo-and hyperthyroidism alter the structure of growth plate cartilage and modify chondrocyte gene expression in vivo, whilst TR mutations or deletions in mice result in altered growth plate architecture. Nevertheless, the particular roles of individual TR isoforms in mediating T 3 action in chondrocytes have not been studied and are difficult to determine in vivo because of complex cellular and molecular interactions that regulate growth plate maturation. Therefore, we studied the effects of TRa and TRb on chondrocyte growth and differentiation in primary cultures of neonatal rib chondrocytes isolated from TRa-and TRb-deficient mice. T 3 decreased proliferation but accelerated differentiation of rib chondrocytes from wild-type mice. T 3 treatment resulted in similar effects in TRa-deficient chondrocytes, but in TRbdeficient chondrocytes, all T 3 responses were abrogated. Furthermore, T 3 increased TRb1 expression in wild-type and TRa-deficient chondrocytes. These data indicate that T 3 -stimulated differentiation of primary rib chondrocytes in vitro requires TRb and suggest that the TRb1 isoform mediates important T 3 actions in mouse rib chondrocytes.
Introduction
Triiodothyronine (T 3 ) plays a key role in bone growth and maturation (Bassett & Williams 2003) . Hypothyroidism results in growth retardation, epiphyseal dysgenesis and delayed bone mineralization. In contrast, thyrotoxicosis accelerates growth and advances bone age, but causes short stature due to early closure of the growth plates. Longitudinal growth results from proliferation of growth plate chondrocytes, differentiation of proliferating chondrocytes and enlargement of hypertrophic chondrocytes, which increase their volume by tenfold during maturation. Hypertrophic chondrocytes also play a key role in the control of bone vascularization and thus regulate endochondral ossification (Gerber & Ferrara 2000 , Goldring et al. 2006 .
Both hypothyroidism and thyrotoxicosis alter the structure and organization of the growth plate in vivo (Lewinson et al. 1994 , Freitas et al. 2005 . Hypothyroidism increases the width of the proliferative zone but reduces the size of the hypertrophic zone. In contrast, thyrotoxicosis results in a reduced width of both proliferative and hypertrophic zones. Nevertheless, the mechanisms by which altered thyroid status regulates the growth plate remain unclear. In vivo, thyroid hormones regulate expression of parathyroid hormone related peptide (PTHrP) and PTHrP receptors, which control the pace of chondrocyte proliferation during endochondral ossification . In organ cultures, thyroxine (T 4 ) is a potent stimulator of chondrocyte differentiation (Wakita et al. 1998 , Miura et al. 2002 , whilst in vitro T 3 decreases the growth of chondrocyte colonies and inhibits cell proliferation (Bohme et al. 1992 , Ohlsson et al. 1992 , Okubo & Reddi 2003 . Many investigators have also demonstrated a positive role for T 3 in regulating terminal differentiation of chondrocytes in vitro in several species using different culture systems (Ohlsson et al. 1992 , Quarto et al. 1992 , Ballock & Reddi 1994 , Bohme et al. 1995 , Alini et al. 1996 , Leboy et al. 1997 , Ishikawa et al. 1998 , Okubo & Reddi 2003 . Mechanistic studies have revealed that thyroid hormone (TH) stimulates expression of p21, a cyclin D1 inhibitor, in rat epiphyseal chondrocytes in vitro (Ballock et al. 2000) and inhibits the expression of Sox-9, a transcription factor that maintains chondrocytes in an undifferentiated state, in mouse rib chondrocytes (Okubo & Reddi 2003) . Furthermore, T 3 stimulates fibroblast growth factor (FGF) receptor expression in ATDC5 cells and enhances FGF signalling in these cells and also in primary mouse rib chondrocytes (Barnard et al. 2005) . However, precisely how these responses are involved in the T 3 control of chondrocyte proliferation and differentiation has not been determined.
T 3 actions are mediated by nuclear T 3 receptors (TR) (Yen et al. 2006) , which act as ligand-controlled transcription factors. TRa1 is encoded by the TRa gene, which also encodes TRa2, TRDa1 and TRDa2 isoforms that do not bind T 3 and whose function is largely unknown. TRa1 and TRa2 are expressed in chondrocytes and osteoblasts. TRb1, TRb2 and TRb3 are encoded by the TRb gene. TRb1 is expressed in chondrocytes and osteoblasts. Mice which lack TRa1 and TRa2 display abnormal growth plate architecture and impaired long bone mineralization during post-natal growth associated with reduced FGFR1 and FGFR3 expression in osteoblasts and chondrocytes (Stevens et al. 2003 , Barnard et al. 2005 . Introduction of a point mutation into the TRa gene results in the expression of a dominant-negative TRa protein that inhibits the function of wild-type TRs and causes a similar, but more severe, skeletal phenotype than that observed in TRadeficient mice . In contrast, mice with the homologous mutation in TRb have elevated TH levels, advanced bone age and short stature with a reduced width of the growth plates affecting both the proliferative and the hypertrophic zones. These features have been interpreted to result from elevated TH levels acting via intact TRa1 in bone . Nevertheless, a specific role for TRb in chondrocytes has also been suggested by studies of the TRb selective agonist GC-1 (Freitas et al. 2005) . Hypothyroid rats exhibited disorganized chondrocytes columns, reduced hypertrophic chondrocyte differentiation and impaired mineralization. These abnormalities were all rescued by the administration of T 3 , whereas the TRb-selective agonist GC-1 also rescued the chondrocyte differentiation and bone mineralization defects but was unable to restore normal growth plate architecture.
In vivo analysis of mechanisms that account for T 3 action in the growth plate is difficult because of the complex interactions between chondrocytes and other cell types and because of the interplay between T 3 and other endocrine and paracrine systems, which may be affected by TR genetic modifications. In particular, local concentrations of thyroid hormone can be affected by these mutations: TRb K/K mice have been shown not only to have elevated TH levels, but also to have altered expression of de-iodinases in some tissues, including liver (Amma et al. 2001 ) and cochlea (CamposBarros et al. 2000) , thus modifying the local metabolism of TH. The aim of this study was to determine the roles of TRa and TRb in T 3 -stimulation of chondrocyte growth, differentiation and maturation, in an in vitro system, which allows a precise control of TH concentration. For this purpose, we isolated chondrocytes from the ribs of newborn mice. Murine rib chondrocytes cultured in a monolayer maintain a differentiated phenotype of round or polygonal cells that express type II collagen (Lefebvre et al. 1994) . Cells differentiate in response to bone morphogenetic protein-2 (BMP-2) (Valcourt et al. 2003 , Yagi et al. 2003 ), but may de-differentiate after several passages if cultured at low density (Lefebvre et al. 1994) or when maintained in the presence of TGFb1 (Valcourt et al. 2002) . To analyse the roles of TRa and TRb, we isolated rib chondrocytes from mice, which lack either TRa (TRa 0/0 mice) or TRb (TRb K/K mice) (Gauthier et al. 1999) . We measured the expression of TR isotypes at different times of the culture. We monitored the growth of the cultures by measuring the amount of DNA and evaluated the differentiation by measuring the activity of alkaline phosphatase (ALP) and the expression of collagen X.
Materials and Methods

Animals and cell culture
Mice were maintained with a ratio of 12 h light:12 h darkness cycle at 22-26 8C and experiments performed according to requirements of the regional committee of Ethics and the National Committee of Genetics. Homozygous wild type, TRa 0/0 and TRb K/K mice were crossed to obtain homozygous offspring. Neonatal ribs were dissected as described (Lefebvre et al. 1994) . Cells were dissociated in 2 mg/ml protease (Sigma) for 20 min, washed in PBS, incubated in 2 mg/ml collagenase (Sigma) for 10 min, washed thrice in PBS, and incubated in 2 mg/ml collagenase for 5 h. The cell pellet was resuspended in DMEM/F12 medium (Gibco, Life Technology) supplemented with 10% heat-inactivated foetal bovine serum and 2 mM L-glutamine (Gibco), penicillin, streptomycin and gentamycin. Cells were seeded into 75 cm 2 flasks at a density of 50 000/cm 2 . Confluent cells were trypsinized and seeded into 96-or 6-well plates at the same density and after 48 h the medium was replaced by a serum-free medium containing 1:500 ITS (Bio-Whittaker, Walkersville, Cambrex), 1 mg/ml BSA and combinations of 10 K7 M T 3 (Sigma) and 100 ng/ml BMP-2 (Peprotech, Tebu).
Cell growth and ALP activity
Cells were harvested at several time points after seeding by washing twice in PBS and freeze-thawing in 50 ml Hoechst 33258 solution (5 mg/ml in 10 mM Tris-HCl, pH 8$0, 150 mM NaCl and 0$1 mM EDTA). DNA concentration was determined in a Cytofluometer2 multi-well fluorometer (excitation 360 nm/emission 460 nm) compared with a standard curve prepared from calf thymus DNA. ALP activity was determined by freeze-thawing cells in 50 ml 0$5% Triton X-100 and incubating them for 1-30 min at 37 8C with 50 ml ALP substrate (20 mM p-nitrophenyl phosphate) in alkaline buffer solution (Sigma). Absorbance was determined at 405 nm in a fluorescence microplate reader (MRX, Dynex Technologies) and ALP activity was estimated compared with a standard curve prepared from a p-nitrophenol solution (Sigma), normalized to DNA concentration and expressed as nanomoles/minute per microgram DNA.
Analysis of gene expression by real-time quantitative RT-PCR (qRT-PCR)
RNA was extracted using an RNeasy Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. Reverse transcription was performed with Superscript II reverse transcriptase (Invitrogen) using 1$25 mg RNA template. One microlitre of tenfold diluted cDNA was used for qRT-PCR, using specific primers (Table 1) to amplify hypoxanthine phosphoribosyl transferase (HPRT), TRb1 (Boelen et al. 2005) , TRa1 and collagen X (Cormier et al. 2003) . Reactions were performed in duplicate for each cDNA using the iQ SYBR Green supermix in an i-cycler IQ thermocycler (Bio-Rad). Quantitation was performed using the Optical System Software (Bio-Rad). Ct values were determined in all amplifications and the mean Ct value for each duplicate was calculated. For each RNA extraction, the mean DCt between the gene of interest and the HPRT gene was calculated. For each series of analyses, the reference sample was derived from untreated wild-type cells at the earliest time point of the culture, or from tissues of untreated wild-type mice. This reference value (DCt 0 ) was subtracted from the DCt values of all other samples to give the DDCt value; thus, the DDCt value of the reference sample was zero. The relative amount of cDNA in each sample was calculated using the formula RQZ 2 KDDCt ; thus the quantity of cDNA in the reference sample was 1.
Statistical analysis
Statistical analysis was performed using unpaired two-tailed Student's t-tests and a P value !0$05 was considered significant. These analyses were performed by comparing the data obtained from multiple wells for each experimental condition, within one primary culture. All the results presented in this manuscript have been repeated at least in three independent primary cultures for each genotype.
Results
Expression of TRa and TRb isoforms in rib chondrocytes
Expression of TR isoforms in rib chondrocytes was determined over 21 days in culture by qRT-PCR. In the absence of T 3 , TRb1 expression (Fig. 1A) was similar in wild type and TRa 0/0 cells and did not vary significantly with time, other than a 50% decrease at day 12 compared with day 6 in wild-type cells. In the presence of T 3 , TRb1 expression increased significantly at days 12 and 21 in the wild-type cells and at days 6 and 21 in TRa 0/0 cells, as compared with the control untreated cells. TRb1 expression in the presence of T 3 did not differ between wild type and TRa 0/0 cells at any time of the culture. In wild-type chondrocytes in the absence of T 3 , TRa1 expression (Fig. 1B) remained constant until day 21. In T 3 -treated cells, TRa1 expression tended to be lower at day 6 and significantly decreased at days 12 and 21 compared with the control untreated cells. In untreated TRb K/K chondrocytes, TRa1 expression was lower than in untreated wild-type cells at all times. T 3 decreased TRa1 expression at day 6 but did not have any effect at days 12 and 21.
T 3 inhibits growth of wild-type and TRa-deficient, but not TRb-deficient rib chondrocytes in the presence of BMP-2
When wild-type rib chondrocytes were grown in 10% foetal bovine serum, cell numbers increased during the first 7 days of culture but remained stable until day 21 ( Fig. 2A) . In serum-free medium, cell numbers declined between day 7 and day 14, but remained stable until day 21. T 3 treatment had no effect on cell growth in serum-free medium. In contrast, treatment with BMP-2 increased cell number by 40-100% at days 7, 14 and 21 (four separate cultures from four different litters, eight wells per treatment for each culture). T 3 significantly decreased the number of cells measured in the presence of BMP-2 at days 7, 14 and 21 by 20-40% in four separate experiments. Thus, T 3 inhibits BMP-2-induced growth of wild-type mouse rib chondrocytes. Chondrocytes from TRa 0/0 mice cultured in 10% serum or in the absence of T 3 displayed a similar pattern of growth as wild-type cells (Fig. 2B) . Treatment with T 3 alone had no significant effect on cell growth. BMP-2 stimulated cell growth by 40-120% (three separate experiments, eight wells per treatment for each culture), and T 3 reduced the cell number obtained in the presence of BMP-2 by 20-30% (three separate experiments). In 10% serum and in the absence of T 3 , chondrocytes from TRb K/K mice had a similar growth pattern to that observed in wild-type cells (Fig. 2C) . T 3 did not modify the growth of TRb K/K chondrocytes. BMP-2 stimulated chondrocyte growth by 25-100%, but T 3 did not significantly affect this stimulation in three separate experiments (eight wells per treatment for each culture).
T 3 stimulates differentiation of wild type and TRa-deficient, but not TRb-deficient rib chondrocytes
Chondrocyte differentiation was monitored by measuring ALP activity at days 14 and 21 (Fig. 3) , and collagen X expression at days 6, 12 and 21 (Fig. 4) . When wild-type chondrocytes were cultured in the absence of T 3 , ALP activity increased by fourfold between day 14 and day 21 (Fig. 3A) . ALP activity was increased five-and threefold at days 14 and 21 respectively, following T 3 treatment. A two-to fivefold stimulation of ALP activity by T 3 was observed at day 21 in five separate experiments. Treatment with BMP-2 elicited a nine-and a fivefold increase in ALP activity at days 14 and 21 respectively, compared with untreated cells. A further 2-to 2$5-fold activation was observed when cells were treated with both BMP-2 and T 3 . In TRa 0/0 chondrocytes, basal ALP activity was stable between days 14 and 21. T 3 increased ALP Hatched bars, 10% FCS; white bars, control, serum-free medium; black bars, serum-free medium with T 3 (10 K7 M); vertically hatched bars, serum-free medium with BMP-2 (100 ng/ml), horizontally hatched bars, serum-free medium with T 3 (10 K7 M) and BMP-2 (100 ng/ml).
activity by 30% at day 14 and by 2$5-fold at day 21 (Fig. 3B) . In four separate experiments, ALP activity was stimulated by T 3 by two-to fivefold in TRa 0/0 chondrocytes. BMP-2 stimulated ALP activity at days 14 and 21 by two-and fourfold respectively. T 3 further increased this activity by 40% at day 14 and twofold at day 21. Notably, ALP activity was lower in TRa 0/0 chondrocytes than wild-type cells in all cultures. In untreated TRb K/K chondrocytes, ALP activity displayed a similar pattern as in wild-type cells, with an increase between days 14 and 21. However, T 3 failed to stimulate ALP activity in TRb K/K chondrocytes (Fig. 3C) . In contrast, BMP-2 stimulated ALP activity 22-fold at day 14 and eightfold at day 21, indicating that TRb K/K chondrocytes retain their differentiation capacity. T 3 had no additional effect on ALP activity in the presence of BMP-2.
Expression of collagen X, another specific marker of chondrocyte differentiation, was also determined (Fig. 4) . Basal expression of collagen X in the absence of T 3 was similar in wild type, TRa 0/0 and TRb K/K chondrocytes throughout the 21-day period of culture. Collagen X expression was increased by T 3 at all times in wild type and TRa 0/0 chondrocytes, but this stimulation was less in TRa 0/0 cells at day 6 compared with wild type. In contrast, T 3 failed to stimulate collagen X expression in TRb K/K chondrocytes.
Discussion
Chondrocytes are sensitive to thyroid hormones in vivo and in vitro (Nilsson et al. 2005) . In vitro, T 3 inhibits cell proliferation but accelerates hypertrophic chondrocyte differentiation; however, the mechanisms responsible for these effects are poorly understood. In order to understand the mechanisms of T 3 action in chondrocytes, it is important to define which TR mediates its biological effects, and thus we investigated chondrocyte proliferation and differentiation in primary cells obtained from TRa and TRb knockout mice. Inhibition of chondrocyte proliferation by T 3 has been demonstrated in several cell culture systems, including epiphyseal chondrocyte monolayer (Ishikawa et al. 1998) and three-dimensional cultures (Ballock et al. 2000 . When mouse rib chondrocytes were cultured in serum-free medium, cell proliferation declined within the first 48 h (data not shown) before reaching a plateau. Addition of T 3 had no effect on cell growth in serum-free medium, which is not surprising because T 3 has not been reported to exert effects on quiescent chondrocyte cultures, although it is has been shown to inhibit expansion of proliferating chondrocyte cultures (Ballock et al. 2000 . In contrast and consistent with studies showing that BMP-2 stimulates mouse growth plate chondrocyte proliferation in vivo (Minina et al. 2001) , BMP-2 not only prevented cell loss but also stimulated growth of primary rib chondrocytes. Importantly, T 3 prevented the BMP-2-induced increase in cell number, indicating that T 3 inhibits BMP-2-stimulated growth of mouse rib chondrocytes. We also demonstrated that growth of TRa-and TRbdeficient chondrocytes in serum-free medium and in the presence of BMP-2 was similar to the growth of wild-type cells, suggesting that TRs do not play a role in T 3 -independent chondrocyte growth. As observed in wild-type cells, T 3 had no effect on the growth of TRa 0/0 or TRb K/K cells in basal medium. Addition of T 3 to BMP-2-treated cultures impaired Figure 3 Effect of T 3 on alkaline phosphatase activity in primary rib chondrocytes. Chondrocytes were cultured for 21 days in the absence or presence of 10 K7 M T 3 G100 ng/ml BMP-2. Alkaline phosphatase activity is expressed as nanomoles of substrate hydrolysed per minute per micrograms of DNAGS.E.M. (nZ4 experiments, eight wells per condition). Results were analysed by two-tailed Student's t-test. NS, not significant. *P!0$001; growth of TRa 0/0 chondrocytes, as observed with wild-type cells, but had no effect on BMP-2-treated TRb
chondrocytes. These data suggest that TRb1 mediates the inhibitory action of T 3 on the BMP-2-stimulated proliferation of mouse rib chondrocytes.
T 3 has been shown to stimulate terminal differentiation of chondrocytes in a variety of systems (Alini et al. 1996 , Leboy et al. 1997 , Ishikawa et al. 1998 , Rosenthal & Henry 1999 , Okubo & Reddi 2003 . In particular, T 3 stimulates ALP activity and increases the expression of collagen X in these models. When mouse rib chondrocytes were cultured for 21 days in serum-free medium in the absence of T 3 , ALP activity and collagen X expression were similar to the levels at the onset of culture, indicating a lack of hypertrophic differentiation. In contrast, in the presence of T 3 , ALP activity increased rapidly and collagen X expression was stimulated at all time points indicating that T 3 stimulates differentiation of primary mouse rib chondrocytes in monolayer cultures.
ALP activity in TRa 0/0 chondrocytes was consistently lower than in wild-type cells in all culture conditions; however, the amplitude of responses to T 3 , BMP-2 and both agents was similar in wild type and TRa-deficient cells. Collagen X expression was also stimulated by T 3 to a similar degree in both TRa 0/0 and wild-type chondrocytes. In contrast, T 3 -stimulation of ALP and collagen X was abolished in TRb K/K chondrocytes. Explanations for this discrepancy include an absence or low proportion of chondrocyte precursors within the ribs of TRb K/K mice, or an impaired intrinsic inability of TRb K/K cells to differentiate into mature chondrocytes. However, BMP-2 stimulated the differentiation of TRb K/K cells to the same extent as in wild type and TRa-deficient cells, indicating that TRb-deficient cells have the intrinsic capacity to differentiate into mature chondrocytes. Furthermore, whereas T 3 could enhance the ALP response of wild type and TRa 0/0 chondrocytes to BMP-2, it had no effect in BMP-2-treated TRb K/K cells. All these data suggest that the T 3 -dependent differentiation pathway is selectively impaired in TRb-deficient cells.
The predominant role of TRb1 in the mediation of T 3 action in mouse rib chondrocytes is consistent with the pattern of expression of TR isoforms during differentiation of wild type and TR-deficient cells. In wild-type cells, T 3 increased expression of TRb1 and decreased expression of TRa1. This differential regulation of TR-isotype expression by T 3 suggests TRb1 as the main mediator of T 3 action in these cells. The observations that, following treatment with T 3 , increased TRb1 expression is preserved in TRa-deficient cells, whereas the decrease in TRa1 expression is attenuated in TRb-deficient cells also support a key role for TRb1. Our observations do not exclude the possibility that in wild-type chondrocytes, both TRs can mediate T 3 action and that TRb1 can substitute for TRa1 in TRa 0/0 cells, whereas TRa1 cannot substitute for TRb1 in TRb K/K cells. Indeed, in the absence of T 3 , the level of expression of TRa1 was lower in TRb K/K than in wild-type cells. One explanation for this low amount of TRa1 in TRbdeficient cells is that TRb1 as an aporeceptor positively regulates the expression of TRa1. The absence of TRb would therefore decrease the expression of TRa1 and diminish the response to T 3 . Consequently, it is possible that TRa1 is active in wild-type cells but, because less abundant, unable to mediate T 3 action in TRb K/K cells. In TRa-deficient cells, the response to T 3 may be mediated by TRb1, however, no compensatory overexpression of this isotype was observed in TRa 0/0 cells. Although it is not possible to exclude that TRa1 is involved in T 3 action in wild-type chondrocytes, upregulation of TRb1 and the downregulation of TRa1 by T 3 in these cells are more consistent with a major role of TRb1. Such a key role of TRb1 in the modulation of chondrocyte differentiation by T 3 is supported by in vivo studies using the TRb-selective agonist GC-1 (Freitas et al. 2005) . In these studies, young hypothyroid rats displayed altered organization of chondrocyte columns within the growth plate with impaired hypertrophic differentiation, as assessed by the decreased size of the hypertrophic zone and reduced expression of collagen X. GC-1, like T 3 , restored normal morphometric parameters of the growth plate and normal expression of collagen X, strongly suggesting that TRb1 mediates the effect of T 3 on chondrocyte differentiation. These findings are consistent with an important role for TRb1 in the control of chondrocyte differentiation and, thus, the role of TRa1 in chondrocyte biology remains to be elucidated. In hypothyroid rats, T 3 , but not the TRb-selective agonist GC-1, restored normal organization of the growth plate, suggesting that TRa1 mediates the effects of T 3 on the spatial organization of chondrocytes (Freitas et al. 2005) . However, our findings using rib chondrocytes in monolayer cultures did not demonstrate a major role for TRa in the regulation of cell proliferation and differentiation. It is possible that, in vivo or in a three-dimensional environment, TRa1 is the key mediator of T 3 action, whereas in monolayer cultures, TRb1 becomes predominant. Nonetheless, in TRa 0/0 -chondrocytes, ALP activity was blunted compared with wild-type cells, raising the possibility that TRa may be a permissive factor that facilitates chondrocyte differentiation. The importance of TRa is further suggested by the growth plate phenotype of mice lacking the TRa gene (Fraichard et al. 1997 or expressing a dominant negative TRa1 isoform . These mice have disorganized chondrocyte columns and reduced width of the hypertrophic zone. However, they also have mild hypothyroxinemia (Macchia et al. 2001 , Weiss et al. 2002 , raising the possibility that the observed phenotype results from reduced local TH availability.
Altogether, our data are consistent with the observations from TR-knockout and knock-in mice, and suggest that TRb1 mediates important T 3 effects on hypertrophic chondrocyte terminal differentiation, whereas TRa1 is likely to be involved in the control of cellular and molecular interactions that are important for the three-dimensional organization of growth plate cartilage and the initiation of chondrocyte differentiation. These findings may have important applications for the potential use of T 3 analogues as therapeutic agents for the treatment of bone and articular cartilage lesions.
